Evidence map›Paper›PMID 24327585›Full record

ArticleNeuro-oncology2014

Hippocampal sparing radiotherapy for pediatric medulloblastoma: impact of treatment margins and treatment technique.

N Patrik Brodin, Per Munck af Rosenschöld, Malin Blomstrand, Anne Kiil-Berthlesen, Christian Hollensen, Ivan R Vogelius, Birgitta Lannering, Søren M Bentzen, Thomas Björk-Eriksson

Open access · bronzeAbstract read
In one paragraph

Article in Neuro-oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Experimental validation of proton physics models of Geant4 for calculating stopping power ratio.Journal of radiological protection : official journal of the Society for Radiological Protection · 2022
    Article
  11. Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.International journal of radiation oncology, biology, physics · 2021
    Review
  12. Dosimetric impact of range uncertainty in passive scattering proton therapy.Journal of applied clinical medical physics · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. A prospective evaluation of hippocampal radiation dose volume effects and memory deficits following cranial irradiation.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2017
    Article
  17. Proton Beam Therapy for Pediatric Brain Tumor.Neurologia medico-chirurgica · 2017
    Review
  18. Article
  19. Changes in Imaging and Cognition in Juvenile Rats After Whole-Brain Irradiation.International journal of radiation oncology, biology, physics · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

N Patrik BrodinDepartment of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden (M.B.); Centre for Brain Repair and Rehabilitation, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden (M.B.); Radiation Medicine Research Center, Department of Radiation Oncology, Rigshospitalet, Copenhagen, Denmark (N.P.B., P.M.R., A.K.-B., C.H., I.R.V., S.M.B.); Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark (N.P.B., P.M.R.); Department of Clinical Physiology and Nuclear Medicine, Centre of Diagnostic Investigations, Copenhagen, Denmark (A.K.-B.); Department of Pediatric Oncology, the Queen Silvia Children's Hospital, University of Gothenburg, Gothenburg, Sweden (B.L.); Department of Human Oncology, University of Wisconsin Medical School, Madison, Wisconsin (S.M.B.); Department of Radiation Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden (T.B.-E.).
Per Munck af Rosenschöld
Malin Blomstrand
Anne Kiil-Berthlesen
Christian Hollensen
Ivan R Vogelius
Birgitta Lannering
Søren M Bentzen
Thomas Björk-Eriksson
Sahlgrenska University Hospital · SEUniversity of Gothenburg · SERigshospitalet · DKUniversity of Copenhagen · DKUniversity of Wisconsin–Madison · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
NCI NIH HHS 2P30 CA014520-34NCI NIH HHS P30 CA014520
6 · The paper itself

Abstract

backgroundWe investigated how varying the treatment margin and applying hippocampal sparing and proton therapy impact the risk of neurocognitive impairment in pediatric medulloblastoma patients compared with current standard 3D conformal radiotherapy.

methodsWe included 17 pediatric medulloblastoma patients to represent the variability in tumor location relative to the hippocampal region. Treatment plans were generated using 3D conformal radiotherapy, hippocampal sparing intensity-modulated radiotherapy, and spot-scanned proton therapy, using 3 different treatment margins for the conformal tumor boost. Neurocognitive impairment risk was estimated based on dose-response models from pediatric CNS malignancy survivors and compared among different margins and treatment techniques.

resultsMean hippocampal dose and corresponding risk of cognitive impairment were decreased with decreasing treatment margins (P < .05). The largest risk reduction, however, was seen when applying hippocampal sparing proton therapy-the estimated risk of impaired task efficiency (95% confidence interval) was 92% (66%-98%), 81% (51%-95%), and 50% (30%-70%) for 3D conformal radiotherapy, intensity-modulated radiotherapy, and proton therapy, respectively, for the smallest boost margin and 98% (78%-100%), 90% (60%-98%), and 70% (39%-90%) if boosting the whole posterior fossa. Also, the distance between the closest point of the planning target volume and the center of the hippocampus can be used to predict mean hippocampal dose for a given treatment technique.

conclusionsWe estimate a considerable clinical benefit of hippocampal sparing radiotherapy. In choosing treatment margins, the tradeoff between margin size and risk of neurocognitive impairment quantified here should be considered.

Indexed as

HippocampusOrgan Sparing TreatmentsProton TherapyRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedAdolescentCerebellar NeoplasmsChildChild, PreschoolFemaleFollow-Up StudiesHumansMaleMedulloblastomaOrgans at RiskPrognosiscognitive risk estimationhippocampal sparingmedulloblastomatumor bed boost

Identifiers

PMID24327585
PMCPMC3956350
OpenAlexW2160209270

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.